Innovations in the systemic therapy of prostate cancer

被引:0
|
作者
Dale R. Shepard
Derek Raghavan
机构
[1] Taussig Cancer Institute,Department of Solid Tumor Oncology
[2] Cleveland Clinic,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Important innovations have been achieved in the development of novel systemic hormonal therapies for the salvage treatment of metastatic castrate-resistant disease. The use of chemotherapy as an adjunct for the treatment of castrate-resistant metastatic disease and local advanced tumors has also resulted in patterns of late toxic effects. The authors review the important advances in the evolution of systemic therapy for the treatment of prostate cancer.
引用
收藏
页码:13 / 21
页数:8
相关论文
共 50 条
  • [21] Burden of Disease Matters When It Comes to Systemic Therapy for Prostate Cancer
    Harrison, Michael R.
    Armstrong, Andrew J.
    EUROPEAN UROLOGY, 2015, 67 (03) : 448 - 450
  • [22] IN SITU GENE THERAPY FOR PROSTATE CANCER ITS LOCAL AND SYSTEMIC EFFECT
    Nasu, Yasutomo
    Kumon, Hiromi
    JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1018 - 1018
  • [23] Androgen deprivation therapy in prostate cancer. Indication and systemic consequences
    Rohayem, J.
    Kliesch, S.
    UROLOGE, 2012, 51 (04): : 557 - 564
  • [24] Chemotherapy for prostate cancer: implementing early systemic therapy to improve outcomes
    Gary R. MacVicar
    Maha Hussain
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 69 - 77
  • [25] SYSTEMIC TRIPLE THERAPY IN METASTATIC HORMONE SENSITIVE PROSTATE CANCER (MHSPC)
    Omrcen, Tomislav
    ACTA CLINICA CROATICA, 2022, 61 : 81 - 85
  • [26] Optimal systemic therapy in men with low-volume prostate cancer
    Saxena, Akshat
    Andrews, Jack
    Bryce, Alan Haruo
    Riaz, Irbaz Bin
    CURRENT OPINION IN UROLOGY, 2024, 34 (03) : 183 - 197
  • [27] Navigating systemic therapy for metastatic castration-naive prostate cancer
    Kwan, E. M.
    Thangasamy, I. A.
    Teh, J.
    Alghazo, O.
    Sathianathen, N. J.
    Lawrentschuk, N.
    Azad, A. A.
    WORLD JOURNAL OF UROLOGY, 2021, 39 (02) : 339 - 348
  • [28] Advanced prostate cancer: Systemic radiopharmaceutical therapy of metastatic prostate cancer with rhenium-186 hydroxyethylidene diphosphonate
    Lerch, H
    Schober, O
    STRAHLENTHERAPIE UND ONKOLOGIE, 1998, 174 (07) : 384 - 385
  • [29] Underutilization of best systemic therapy in patients with metastatic prostate cancer.
    Roadman, Daniel
    Cao, David
    Vourganti, Srinivas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [30] Update in systemic therapy of prostate cancer: improvement in quality and duration of life
    Vaishampayan, Ulka
    Hussain, Maha
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (02) : 269 - 281